ATC
CLPT icon

Adirondack Trust Company’s ClearPoint Neuro CLPT Stock Holding History

Adirondack Trust Company’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-880
Closed -$4.74K – 491
2024
Q2 		$4.74K Hold
880
– – ﹤0.01% 409
2024
Q1 		$5.98K Hold
880
– – ﹤0.01% 398
2023
Q4 		$5.62K Hold
880
– – ﹤0.01% 401
2023
Q3 		$4.4K Hold
880
– – ﹤0.01% 416
2023
Q2 		$6.04K Hold
880
– – ﹤0.01% 377
2023
Q1 		$7.43K Hold
880
– – ﹤0.01% 362
2022
Q4 		$7.45K Hold
880
– – ﹤0.01% 357
2022
Q3 		$9K Hold
880
– – 0.01% 327
2022
Q2 		$11K Hold
880
– – 0.01% 298
2022
Q1 		$9K Buy
880
+510
+138% +$4.64K ﹤0.01% 322
2021
Q4 		$4K Buy
+370
New +$5.54K ﹤0.01% 371

Other funds holding CLPT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return

Adirondack Trust Company's CLPT Position: Q3 2024 in Review

Adirondack Trust Company sold out of ClearPoint Neuro (CLPT) in Q3 2024, closing a stake of 880 shares — an estimated $4.74K sold.

Adirondack Trust Company first reported a position in CLPT in Q4 2021 and held it in 11 quarters. The position peaked at $11K in Q2 2022. 78 funds tracked by Wall St. Rank hold CLPT as of Q3 2024.

  • Adirondack Trust Company reported no remaining ClearPoint Neuro position as of Q3 2024 after selling out during the quarter.
  • Adirondack Trust Company sold 880 ClearPoint Neuro shares in Q3 2024, an estimated $4.74K.
  • Adirondack Trust Company first reported a position in ClearPoint Neuro in Q4 2021 and held it in 11 quarters.
  • Adirondack Trust Company's ClearPoint Neuro position peaked at $11K in Q2 2022.
  • 78 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2024.

Based on Adirondack Trust Company's 13F filing for Q3 2024, filed 8 Oct 2024.